Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Numiglide-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Numera Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Numiglide-M 1 Tablet PR

Diabexe Duo, a single-dose tablet, is an antidiabetic medication combining two active ingredients for adult type 2 diabetes management. It effectively regulates blood glucose. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabexe Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring and potential blood tests (to assess blood cell counts and liver function) are recommended by your physician.

Uses of Numiglide-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Numiglide-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer one Numiglide-M PR tablet with a meal.

Common Side effects of Numiglide-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Numiglide-M 1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Consume one Numiglide-M tablet (PR) with a meal.

How Numiglide-M 1 Tablet PR works:

Numiglide-M PR, a single-tablet formulation, combines glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Numiglide-M 1 Tablet PR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Numiglide-M 1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Administration of Numiglide-M 1 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Numiglide-M 1 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Numiglide-M 1 Tablet PR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Numiglide-M 1 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation with a low Numiglide-M 1 Tablet PR dosage is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Numiglide-M 1 Tablet PR :

Should you forget a Numiglide-M 1 Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Numiglide-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Numiglide-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Numiglide-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Numiglide-M 1 Tablet PR and seek immediate medical attention.
Numiglide-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's unsuitable for treating type 1 DM.
Numiglide-M 1 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Numiglide-M 1 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Numiglide-M 1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Numiglide-M 1 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Numiglide-M 1 Tablet PR
33
MRP 40
17% off